Payward, the parent company of cryptocurrency exchange Kraken, has reportedly paused its initial public offering (IPO) plans as broader market ...

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going in 2026?

Crypto and AI-based initial public offerings last year reportedly dragged down the performance of all US public debuts to fall behind the tech-heavy index S&P 500. Shares of all companies that went ...

To understand what’s holding the 2026 IPO market back and what could unlock it, Crunchbase News recently spoke with Mike ...

The life sciences industry is poised for an upswing in initial public offering (IPO) activity in 2026, supported by a large IPO backlog, the strong performance of biotech market indices, and positive ...

PhonePe has filed its Updated Draft Red Herring Prospectus with SEBI, moving closer to its IPO. The offering includes 50.66 ...

Investors would have been better off investing in the S&P500 than betting on US initial public offerings in 2025, with crypto and AI public debuts partly to blame. Crypto and AI-based initial public ...